Form 4: J.H. Whitney Equity Partners VII, LLC Sells Aveanna Healthcare Holdings Inc. Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares held by related entities under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • J.H. Whitney Equity Partners VII, LLC filed a Form 4 detailing the sale of Aveanna Healthcare Holdings, Inc. (AVAH) common stock.
  • The sales were executed on May 8 and May 9, 2025, under a Rule 10b5-1 trading plan adopted on December 13, 2024.
  • A total of 52,656 shares were sold on May 8 at an average price of $5.84, and 4,034 shares were sold on May 9 at an average price of $5.55.
  • The shares were sold by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC.
  • Following the reported transactions, J.H. Whitney VII, L.P. beneficially owns 31,319,404 shares, PSA Healthcare Investment Holding LLC beneficially owns 15,647,510 shares, and PSA Iliad Holdings LLC beneficially owns 1,448,598 shares.
  • J.H. Whitney Equity Partners VII, LLC is the general partner of J.H. Whitney VII, L.P. and may be deemed to share voting and dispositive power with respect to the shares held by the Stockholder Entities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. There is no indication of positive or negative outlook.

Industry Context

Sales by large shareholders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The impact on the stock price depends on the size of the sale relative to the trading volume and the overall market sentiment towards Aveanna Healthcare.

Comparison to Industry Standards

  • Comparing these transactions to similar filings from other healthcare companies like Option Care Health (OPCH) or LHC Group (LHCG) shows that insider selling is a regular part of the market, often driven by diversification or personal financial planning.
  • The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading, aligning with practices seen at companies like Amedisys (AMED) and Encompass Health (EHC).

Stakeholder Impact

  • The sale of shares by a major shareholder could create short-term selling pressure on the stock.
  • However, since the sales are conducted under a pre-arranged plan, the impact is likely to be limited.

Key Dates

DateDescription
2024-12-13Date of adoption of Rule 10b5-1 trading plan by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, and PSA Iliad Holdings LLC.
2025-05-08Date of first reported transaction: Sale of Aveanna Healthcare Holdings, Inc. shares.
2025-05-09Date of second reported transaction: Sale of Aveanna Healthcare Holdings, Inc. shares.
2025-05-12Date of signature on the Form 4 filing.

Keywords

Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners VII, share sale, Form 4, 10b5-1 plan, securities transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.